NCT04205812 2026-03-31POD1UM-304Incyte CorporationPhase 3 Active not recruiting583 enrolled 22 charts
NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT03383094 2025-10-07Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerUniversity of California, San DiegoPhase 2 Active not recruiting126 enrolled
NCT02711553 2025-08-03A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract CancerEli Lilly and CompanyPhase 2 Active not recruiting309 enrolled 22 charts
NCT05294172 2025-05-30KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaSichuan Kelun Pharmaceutical Research Institute Co., Ltd.Phase 3 Active not recruiting295 enrolled